FDA advisers endorse 1st Covid-19 shots for kids under 5
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Monday
August 08, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
MONDAY, AUGUST 08, 2022
FDA advisers endorse 1st Covid-19 shots for kids under 5

Coronavirus chronicle

UNB
16 June, 2022, 11:55 am
Last modified: 16 June, 2022, 12:07 pm

Related News

  • Agreement signed with World Bank for $300m loan 
  • Children aged 5-11 to get Covid jabs from 11 August
  • BCSIR develops low-priced Covid test kits
  • Biden tests negative for Covid after 'rebound' case, says his physician
  • North Korea marks end of first Covid wave, but risks persist

FDA advisers endorse 1st Covid-19 shots for kids under 5

The Food and Drug Administration’s vaccine advisers gave a thumbs-up to vaccines from Moderna and Pfizer for the littlest kids

UNB
16 June, 2022, 11:55 am
Last modified: 16 June, 2022, 12:07 pm
Vials labelled "AstraZeneca, Pfizer - Biontech, Johnson&Johnson, Sputnik V coronavirus disease (Covid-19) vaccine" are seen in this illustration picture taken May 2, 2021. Photo : Reuters
Vials labelled "AstraZeneca, Pfizer - Biontech, Johnson&Johnson, Sputnik V coronavirus disease (Covid-19) vaccine" are seen in this illustration picture taken May 2, 2021. Photo : Reuters

The first Covid-19 shots for US infants, toddlers and preschoolers moved a step closer Wednesday.

The Food and Drug Administration's vaccine advisers gave a thumbs-up to vaccines from Moderna and Pfizer for the littlest kids.

The outside experts voted unanimously that the benefits of the shots outweigh any risks for children under 5 — that's roughly 18 million youngsters. They are the last age group in the US without access to Covid-19 vaccines and many parents have been anxious to protect their little children.

If all the regulatory steps are cleared, shots should be available next week.

"This is a long-awaited vaccine," said one panel member, Dr. Jay Portnoy of Children's Hospital in Kansas City, Missouri. "There are so many parents who are absolutely desperate to get this vaccine and I think we owe it to them to give them a choice to have the vaccine if they want to."

Dr. Peter Marks, FDA's vaccine chief, opened the meeting with data showing a "quite troubling surge" in young children's hospitalizations during the omicron wave, and noted 442 children under 4 have died during the pandemic. That's far fewer than adult deaths, but should not be dismissed in considering the need for vaccinating the youngest kids, he said.

"Each child that's lost essentially fractures a family," Marks said.

While endorsing the vaccines, some panel members said they believe chances are minimal for severe illness and death in young children.

"Risks from vaccination are very low, but so are risks from Covid-19 for the youngest kids," said Dr. Cody Meissner of Tufts University.

FDA reviewers said both brands appear to be safe and effective for children as young as 6 months old in analyses posted ahead of the all-day meeting. Side effects, including fever and fatigue, were generally minor in both, and less common than seen in adults.

The two vaccines use the same technology but there are differences. In a call with reporters earlier this week, vaccine experts noted that the shots haven't been tested against each other, so there's no way to tell parents if one is superior.

"You can't compare the vaccines directly," said Dr. Jesse Goodman of Georgetown University, a former FDA vaccine chief.

 

If the FDA agrees with its advisers and authorizes the shots, there's one more step. The Centers for Disease Control and Prevention will decide on a formal recommendation after its own advisers vote on Saturday. If the CDC signs off, shots could be available as soon as Monday or Tuesday at doctor's offices, hospitals and pharmacies.

Pfizer's vaccine is for children 6 months through 4 years; Moderna's vaccine is for 6 months through 5 years.

Moderna's shots are one-quarter the dose of the company's adult shots. Two doses appeared strong enough to prevent severe illness but only about 40% to 50% effective at preventing milder infections. Moderna added a booster to its tests and expects to eventually offer one.

Pfizer's shots are just one-tenth its adult dose. Pfizer and partner BioNTech found that two shots didn't provide enough protection in testing, so a third was added during the omicron wave.

 

Pfizer's submitted data found no safety concerns and suggested that three shots were 80% effective in preventing symptomatic coronavirus infections. But that was based on just 10 Covid-19 cases; the calculation could change as more cases occur in the company's ongoing studies.

Several advisers, noting that protection is low after two Pfizer doses, worried that some parents might end up skipping the third shot, or mistakenly thinking their kids are better protected between shots, leaving them vulnerable.

Educating parents must be done "very very carefully so that they are not misled about what the vaccines actually provide," said Dr. Archana Chatterjee of Rosalind Franklin University.

The same FDA panel on Tuesday backed Moderna's half-sized shots for ages 6 to 11 and full-sized doses for teens. If authorized by the FDA, it would be the second option for those age groups. Currently Pfizer vaccine is their only choice.

The nation's vaccination campaign started in December 2020 with the rollout of adult vaccines from Pfizer and Moderna, with health care workers and nursing home residents first in line. Teens and school-age children were added last year.

Moderna said in April that it is also seeking regulatory approval outside the US for its little kid shots. According to the World Health Organization, 12 countries already vaccinate kids under 5, with other brands.

In the US, it remains uncertain how many parents want their youngest vaccinated. By some estimates, three-quarters of all children have already been infected. And only about 29% of children aged 5 to 11 have been vaccinated since Pfizer's shots opened to them last November, a rate far lower than public health authorities consider ideal.

Dr. Nimmi Rajagopal, a family medicine physician at Cook County Health in Chicago, said she's been preparing parents for months.

"We have some that are hesitant, and some that are just raring to go," she said.

 

World+Biz

COVID-19 / vaccines / children

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Denim industry banks on new tech for further leap
    Denim industry banks on new tech for further leap
  • More strain on inflation as fuel price soars : After new fuel prices took effect, owners of cars and motorbikes paid around 50% more than the previous rates for petrol and octane. The photo was taken at a filling station in the capital's Paribagh area on Saturday. Photo: Rajib Dhar
    Fuel price hike leads to a transportation mayhem
  • Photo: TBS
    Bangamata's 92nd birth anniversary being observed

MOST VIEWED

  • People line up for nucleic acid tests during lockdown, amid the coronavirus disease (COVID-19) pandemic, in Shanghai, China, May 26, 2022. REUTERS/Aly Song
    China's Sanya holiday hotspot shuts duty-free malls, venues to curb Covid
  • FILE PHOTO: People wearing protective face masks walk amid concerns over the new coronavirus disease (COVID-19) in Pyongyang, North Korea May 15, 2020, in this photo released by Kyodo. Mandatory credit Kyodo/via REUTERS
    North Korea marks end of first Covid wave, but risks persist
  • A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
    South Africa reports first death causally linked to Covid vaccine
  • 'Living with Covid': Where the pandemic could go next
    'Living with Covid': Where the pandemic could go next
  • A worker, wearing a protective suit following the coronavirus disease (COVID-19) outbreak, transports luggage on the tarmac of Wuhan Tianhe International Airport, on a hot summer day in Wuhan, Hubei province, China July 14, 2022. cnsphoto via REUTERS
    China's Wuhan locks down 1m residents amid new Covid cases
  • Covid: CDC flags Bangladesh and 5 other countries as ‘high risk’ for travel
    Covid: CDC flags Bangladesh and 5 other countries as ‘high risk’ for travel

Related News

  • Agreement signed with World Bank for $300m loan 
  • Children aged 5-11 to get Covid jabs from 11 August
  • BCSIR develops low-priced Covid test kits
  • Biden tests negative for Covid after 'rebound' case, says his physician
  • North Korea marks end of first Covid wave, but risks persist

Features

Will Glass Cosmetics be your next skincare holy grail?

Will Glass Cosmetics be your next skincare holy grail?

1h | Brands
Akij Tableware: More than just dishes on a table

Akij Tableware: More than just dishes on a table

2h | Brands
Deeply depressed and afraid of living in total darkness, the Noakhali-based housewife Rasheda desires nothing but to get her vision back. Photo: Noor-A-Alam

Blind people need 25,000 corneas. Sandhani gets around 25

3h | Panorama
Picture: Collected

The six billion dollar man

4h | Panorama

More Videos from TBS

First Aid for Stroke: What you should know

First Aid for Stroke: What you should know

1h | Videos
Is smartphone use reducing our memory?

Is smartphone use reducing our memory?

3h | Videos
City dwellers in trouble due to lack of public transport

City dwellers in trouble due to lack of public transport

3h | Videos
Oil prices fall due to recession fears

Oil prices fall due to recession fears

3h | Videos

Most Read

1
Diesel price hiked by Tk34 per litre, Octane by Tk46
Energy

Diesel price hiked by Tk34 per litre, Octane by Tk46

2
Housing projects sprouting up by Dhaka-Mawa expressway
Real Estate

Housing projects sprouting up by Dhaka-Mawa expressway

3
July remittance hits two-year high
Economy

July remittance hits two-year high

4
Infographic: TBS
Banking

Dollar rate will be left to market after two months: Governor

5
Bangladesh to resume talks for Ukrainian wheat import
Economy

Bangladesh to resume talks for Ukrainian wheat import

6
A liquefied natural gas (LNG) tanker is tugged towards a thermal power station in Futtsu, east of Tokyo, Japan November 13, 2017. REUTERS/Issei Kato/File Photo
Energy

Summit proposes long-term LNG supply to Petrobangla

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net